Fucoidan as a potential therapeutic for major blinding diseases-A hypothesis

42Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

Abstract

Fucoidan is a heterogeneous group of sulfated polysaccharide with a high content of L-fucose, which can be extracted from brown algae and marine invertebrates. It has many beneficial biological activities that make fucoidan an interesting candidate for therapeutic application in a variety of diseases. Age-related macular degeneration and diabetic retinopathy are major causes for vision loss and blindness in the industrialized countries and increasingly in the developing world. Some of the characteristics found in certain fucoidans, such as its anti-oxidant activity, complement inhibition or interaction with the Vascular Endothelial Growth factor, which would be of high interest for a potential application of fucoidan in age-related macular degeneration or diabetic retinopathy. However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological activities of fucoidan that could be of interest regarding these diseases will be discussed.

Cite

CITATION STYLE

APA

Klettner, A. (2016, February 1). Fucoidan as a potential therapeutic for major blinding diseases-A hypothesis. Marine Drugs. MDPI AG. https://doi.org/10.3390/md14020031

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free